相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis
Davy Vancampfort et al.
WORLD PSYCHIATRY (2016)
Premature Mortality Among Adults With Schizophrenia in the United States
Mark Olfson et al.
JAMA PSYCHIATRY (2015)
General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial
D. E. Kemp et al.
ACTA PSYCHIATRICA SCANDINAVICA (2014)
Body Mass Index Identified as an Independent Predictor of Psychiatric Readmission
Peter Manu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Markers of inflammation in schizophrenia: association vs. causation
Peter Manu et al.
WORLD PSYCHIATRY (2014)
Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders Baseline Results From the RAISE-ETP Study
Christoph U. Correll et al.
JAMA PSYCHIATRY (2014)
Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators
Davy Vancampfort et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study
Daniel J. Smith et al.
BMC MEDICINE (2013)
Excess Mortality, Causes of Death and Life Expectancy in 270,770 Patients with Recent Onset of Mental Disorders in Denmark, Finland and Sweden
Merete Nordentoft et al.
PLOS ONE (2013)
Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders-A Systematic Review and Meta-Analysis
Alex J. Mitchell et al.
SCHIZOPHRENIA BULLETIN (2013)
A Systematic Review and Meta-Analysis of Recovery in Schizophrenia
Erika Jaaskelainen et al.
SCHIZOPHRENIA BULLETIN (2013)
A meta-analysis of cardio-metabolic abnormalities in drug naive, first-episode and multi-episode patients with schizophrenia versus general population controls
Davy Vancampfort et al.
WORLD PSYCHIATRY (2013)
Comorbidities and Mortality in Bipolar Disorder A Swedish National Cohort Study
Casey Crump et al.
JAMA PSYCHIATRY (2013)
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
Marc De Hert et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?
Marianne Ulcickas Yood et al.
BMC PSYCHIATRY (2011)
Antipsychotic drugs and obesity
Christoph U. Correll et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Mortality in schizophrenia: a measurable clinical endpoint
Chris J. Bushe et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naive Schizophrenia Patients
Jimmi Nielsen et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
Christine Rummel-Kluge et al.
SCHIZOPHRENIA RESEARCH (2010)
Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study
Lauren C. Bresee et al.
SCHIZOPHRENIA RESEARCH (2010)
The impact of obesity on health care costs among persons with schizophrenia
Lydia A. Chwastiak et al.
GENERAL HOSPITAL PSYCHIATRY (2009)
Rehospitalizations among Patients in the Medicare Fee-for-Service Program
Stephen F. Jencks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder
Ruud van Winkel et al.
BIPOLAR DISORDERS (2008)
First- V. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis
M. Smith et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1
Jonathan M. Meyer et al.
SCHIZOPHRENIA RESEARCH (2008)
Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication
Kathleen R. Merikangas et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline
Henry A. Nasrallah et al.
SCHIZOPHRENIA RESEARCH (2006)
From silos to bridges: Meeting the general health care needs of adults with severe mental illnesses
Marcella Horvitz-Lennon et al.
HEALTH AFFAIRS (2006)
Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders
D Cohen et al.
DIABETES CARE (2006)
Consensus development conference on antipsychotic drugs and obesity and diabetes
DIABETES CARE (2004)
The personal impact of schizophrenia in Europe
G Thornicroft et al.
SCHIZOPHRENIA RESEARCH (2004)
Revised prevalence estimates of mental disorders in the United States - Using a clinical significance criterion to reconcile 2 surveys' estimates
WE Narrow et al.
ARCHIVES OF GENERAL PSYCHIATRY (2002)
分享论文
